Old Web
English
Sign In
Acemap
>
Paper
>
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
2020
Ludger Klimek
Oliver Pfaar
Margitta Worm
Thomas Eiwegger
Jan Hagemann
Markus Ollert
Eva Untersmayr
Karin Hoffmann-Sommergruber
Alessandra Vultaggio
Ioana Agache
Sevim Bavbek
Apostolos Bossios
Ingrid Casper
Susan Chan
Alexia Chatzipetrou
Christian Vogelberg
Davide Firinu
Paula Kauppi
Antonios Kolios
Akash Kothari
Andrea Matucci
Oscar Palomares
Zsolt Szépfalusi
Wolfgang Pohl
Wolfram Hötzenecker
Alexander R. Rosenkranz
Karl-Christian Bergmann
Thomas Bieber
Roland Buhl
Jeroen T. M. Buters
Ulf Darsow
Thomas Keil
Jörg Kleine-Tebbe
Susanne Lau
Marcus Maurer
Hans F. Merk
Ralph Mösges
Joachim Saloga
Petra Staubach
Uta Jappe
Klaus Rabe
Uta Rabe
Claus Vogelmeier
Tilo Biedermann
Kirsten Jung
Wolfgang Schlenter
Johannes Ring
Adam Chaker
Wofgang Wehrmann
Sven Becker
Laura Freudelsperger
Norbert Mülleneisen
Katja Nemat
Wolfgang Czech
Holger Wrede
Randolf Brehler
Thomas Fuchs
P. V. Tomazic
Werner Aberer
Antje Henriette Fink-Wagner
F. Horak
Stefan Wöhrl
Verena Niederberger-Leppin
Isabella Pali-Schöll
Regina Roller-Wirnsberger
Otto Spranger
Rudolf Valenta
Mübecell Akdis
Paolo Maria Matricardi
François Spertini
Nicolai Khaltaev
Jean-Pierre Michel
L. Nicod
Peter Schmid-Grendelmeier
Marco Idzko
Eckard Hamelmann
Thilo Jakob
Thomas Werfel
Martin Wagenmann
C. Taube
Erika Jensen-Jarolim
Stephanie Korn
François Hentges
Jürgen Schwarze
Liam O’Mahony
Edward F. Knol
Stefano Del Giacco
Tomás Chivato Pérez
J. Bousquet
Anna Bedbrook
Torsten Zuberbier
Cezmi A. Akdis
Mared Jutel
Keywords:
Pandemic
Coronavirus disease 2019
Immunology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
9
Citations
NaN
KQI
[]